NCT04686175 |
|
Evaluation of Safety Tolerability and Efficacy of INZ-701 in Adults With ENPP1 Deficiency
|
View
|
NCT05734196 |
|
The ENERGY Study Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
|
View
|
NCT05030831 |
|
Evaluation of Safety Tolerability and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE
|
View
|
NCT05050669 |
|
Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency
|
View
|
NCT04372446 |
|
Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency
|
View
|
NCT06302439 |
|
PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency
|
View
|
NCT06657755 |
|
Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients
|
View
|
NCT06462547 |
|
ADAPT Study Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency
|
View
|
NCT05978492 |
|
A Study of TXN10128 in Subjects With Solid Tumors
|
View
|
NCT06046820 |
|
The ENERGY 3 Study Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency
|
View
|
NCT06063681 |
|
A Study of SR-8541A ENPPI Inhibitor in AdvancedMetastatic Solid Tumors
|
View
|
NCT05270213 |
|
Evaluation of RBS2418 in Subjects With Advanced Metastatic Solid Tumors
|
View
|
NCT03758534 |
|
Natural History of GACI With or Without ARHR2 or PXE
|
View
|